When you eat, these cells release GLP-1 into your bloodstream, triggering a cascade of beneficial effects
Skov J, Pedersen M, Holst JJ, Madsen B, Goetze JP, Rittig S, et al
GLP-1-ra and heart failure-related outcomes in patients with and without history of heart failure: an updated systematic review and meta-analysis
Ideal Candidates People who may see the greatest benefit from Retatrutide include those with: Significant weight to lose who have not achieved goals with lifestyle changes alone Type 2 diabetes or prediabetes requiring additional metabolic support Obesity-related health conditions that would improve with substantial weight loss Previous limited success with single or dual-receptor medications Important Considerations Retatrutide may not be appropriate for everyone
210.1 Implementation of patient-reported outcome measures in clinical registries worldwide Rasa Ruseckaite 1 , Randi Jayasinghe 2 , Susannah Ahern 2 , Ashika Maharaj 2 1 Monash University, Melbourne Australia, 2 School of Public Health and Preventive Medicine, Monash University, Melbourne, Victoria, Australia Journal of Patient-Reported Outcomes 2026 , 10(Suppl 1) :210.1 Aims Collection of patient-reported outcomes measures (PROMs) is becoming common in clinical registries worldwide
